A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia

NCT06980428 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants
Dyslipidemia

Interventions

DRUG: AZD4954
DRUG: Placebo

Sponsor

AstraZeneca